Relay Therapeutics Insider Sold Shares Worth $329,322, According to a Recent SEC Filing

MT newswire2026/10/08 21:33

05:33 PM EDT, 10/08/2026 (MT Newswires) -- Thomas Catinazzo, Chief Financial Officer, on October 06, 2026, sold 17,717 shares in Relay Therapeutics (RLAY) for $329,322. Following the Form 4 filing with the SEC, Catinazzo has control over a total of 105,134 common shares of the company, with 105,134 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1812364/000119312526418094/xslF345X05/ownership.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Canadian used car dealer UC Automotive (UCAU.RC.US) files for IPO in the US: aims to raise 29 million USD and list on Nasdaq

Canadian used car dealer UC Automotive has applied for a Nasdaq IPO, aiming to raise up to $29 million, with its main focus on the Greater Vancouver market. Kingswood is the sole underwriter.

智通财经•2026/11/09 06:12

UniCredit: Third-quarter net profit reaches 3.26 billion euros, exceeding expectations

格隆汇•2026/11/09 06:11

UK funds significantly reduced their holdings in SpaceX last week and had fully exited Tesla as of April.

格隆汇•2026/11/09 05:55

Swiss Franc weakens as Fed hawkish outlook lifts USD/CHF

FXStreet•2026/11/09 05:45